- Home
- OCS vs NKTR Comparison
OCS vs NKTR Comparison
Compare OCS & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OCS | NKTR |
|---|---|---|
| Founded | 2003 | 1990 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | OCS | NKTR |
|---|---|---|
| Price | $20.61 | $53.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | $39.80 | ★ $106.33 |
| AVG Volume (30 Days) | 97.6K | ★ 613.8K |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $991,999.00 | ★ $62,600,000.00 |
| Revenue This Year | $35.00 | N/A |
| Revenue Next Year | $874.12 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.00 | $6.48 |
| 52 Week High | $23.08 | $66.92 |
Technical Indicators
Market Signals| Indicator | OCS | NKTR |
|---|---|---|
| Relative Strength Index (RSI) | 57.99 | 44.69 |
| Support Level | $18.64 | $50.49 |
| Resistance Level | $21.86 | $59.23 |
| Average True Range (ATR) | 0.63 | 3.97 |
| MACD | 0.15 | -0.69 |
| Stochastic Oscillator | 62.42 | 19.64 |
Price Performance
Historical ComparisonAbout OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.